From: Mechanistic insight into the impact of nanomaterials on asthma and allergic airway disease
Nanomaterial Properties | Model Characteristics | Disease Related Endpoints | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Material (coating) | Size (nm) | Surface area (m 2 /g) | Agg Size: nm | Species (Strain - Gender) | Allergen (Route) | Particle (Route) | Dose | AHR (LF test) | IgE | Eos | Neu | Lym | MΦ | Total Cells | Pathophysiological Indicators | GCH-MS | Reference |
C | 14 | 300 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | ↑ | ↑ | ↑ | - | ↑ | ↑ | ↑ (IL5, IL13, MCP1, IL6); nc (IL4) | ↑ Goblet cells | [37] |
C | 56 | 45 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | nc | nc | nc | - | nc | ↑ | ↑ (IL5, IL4, IL6, MCP1); nc (IL13) | nc Goblet cells | [37] |
C | 14 | 300 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | - | - | - | - | - | - | ↑ (MIP1α, IL2, IL10, TARC) | - | [38] |
C | 56 | 45 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | - | - | - | - | - | - | ↑ (MIP1α, TARC), nc (IL2, IL10) | - | [38] |
C | 14 | 300 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | ↑ (Resist) | - | - | - | - | - | - | - | nc MUC5AC | [40] |
C | 56 | 45 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | ↑ (Resist) | - | - | - | - | - | - | - | ↑ MUC5AC | [40] |
C | 14 | - | 887 | Mice (BALB/c –f) | OVA (PA) | PA | 2.5 mg/kg x4 | - | ↑ | ↑ | ↑ | - | nc | ↑ | ↑ (CXCL1, IL13), nc (IL4) | - | [41] |
C | 30-50 | - | - | Mice (BALB/c –f) | OVA (IP) | Int N | 11 mg/kg | - | ↑ | ↑ | nc | nc | nc | ↑ | ↑ TNFα, IL4, IL5, IL10, INFγ | ↑ PAS | [42] |
C | 14.3 | 253.9 | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 3.6 mg/kg x3 | - | nc | ↑ | ↑ | nc | nc | ↑ | ↑ (IL4, IL5, IL10, IL13, INFγ, TNFα) | - | [43] |
C | 30-50 | - | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 3.6 mg/kg x3 | - | - | - | - | - | nc | - | ↑ (IL-4, IL-5, IL-10, IL-13, IFN-γ, TNFα) | - | [72] |
C | 14 | 300 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | - | - | - | - | ↑ | ↑ | ↑ (CD86, CD80, MHC II, DEC205, CD19) | - | [39] |
C | 56 | 45 | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.61 mg/kg x6 | - | - | - | - | - | nc | nc | nc (CD86, CD80, MHC II, DEC205, CD19) | - | [39] |
C | 13 | - | <10 μm | Rat (BN –m) | OVA (IP) | Int T | 0.5 mg/kg x3 | nc (Resist) | nc | ↓ | nc | ↑ | nc | nc | nc (INFγ, IL1β, TNFα, IL4, IL5, IL13) | - | [238] |
TiO2 | 29 | 49.8 | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 11 mg/kg | - | ↑ | nc | nc | nc | nc | ↑ | ↑ (TNFα, IL4, IL5, IL10, IL13) nc(INF-γ) | - | [43] |
C70 Fullerene | - | - | - | Mice (BALB/c) | OVA (IP) | Int N | 1.1 mg/kg | ↓ (Resist) | ↓ | ↓ | nc | - | nc | ↓ | ↓ (IL4, IL5), ↑ (CYP1B1) | - | [106] |
Fe2O3 | 35 | 39 | - | Mice (BALB/c –f) | OVA (IP) | Int T | 27.7 mg/kg x4 | - | ↓ | ↓ | nc | ↓ | - | - | ↓ IL4, INFγ | - | [80] |
GO | D 0.6 L 0.02-2μm | - | - | Mice (BALB/c –f) | OVA (IP) | PA | 2.2 mg/kg | ↑ (Penh) | ↓ | ↓ | nc | nc | ↑ | - | ↓ (IL4, IL13) nc (IL5) | ↑ GCH/PAS | [65] |
Latex | 25 | - | - | Mice (ICR –m) | OVA (Int T) | Int T | 13.8 mg/kg | - | nc | nc | ↑ | ↑ | ↑ | ↑ | ↑ (IL18, MIP1α, MCP1); nc (IL5, IL13) | - | [272] |
Latex | 50 | - | - | Mice (ICR –m) | OVA (Int T) | Int T | 13.8 mg/kg | - | nc | nc | ↑ | ↑ | ↑ | ↑ | ↑ (IL18, MIP1α, MCP1); nc (IL5, IL13) | - | [272] |
Latex | 100 | - | - | Mice (ICR –m) | OVA (Int T) | Int T | 13.8 mg/kg | - | nc | nc | nc | nc | nc | nc | ↑ (IL18, MIP1α, MCP1); nc (IL5, IL13) | - | [272] |
PS (Glycine) | 50 | - | - | Mice (BALB/c –f) | OVA (IP) | Int T | 11 mg/kg | - | - | ↓ | nc | ↓ | nc | ↓ | ↓ (IL5, IL13) | - | [79] |
PS | 59 | - | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 16 mg/kg x3 | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | - | - | [44] |
PS | 59 | - | - | Mice (BALB/c –m) | OVA (Int N) | Int N | 16 mg/kg x3 | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | - | - | [44] |
PS (Glycine) | 45-49 | - | - | Mice (BALB/c) | OVA (Int T) | Int T | 11 mg/kg x2 | nc | ↓ | ↓ | nc | nc | nc | ↓ | ↓ (IL-4, IL-5, IL-13), nc (IFN-γ) | ↓ PAS | [78] |
SiO2 | 7 | 300 | - | Mice (C57BL/6-f) | OVA (Inh) | PA | 2.7 mg/kg | - | nc | - | - | - | - | - | ↑(HO1); nc(TNFα,,IL1β, Cxcl2, Ccl2) | - | [55] |
SiO2 | 34 | 80 | - | Mice (C57BL/6-f) | OVA (Inh) | PA | 2.7 mg/kg | - | nc | - | - | - | - | - | ↑(HO1); nc(TNFα,,IL1β, Cxcl2, Ccl2) | - | [55] |
TiO2 (Al(OH)3) | 30-50 | 37.1 | - | Mice (C57BL/6-f) | OVA (Inh) | PA | 2.7 mg/kg | - | nc | - | - | - | - | - | nc (HO1, TNFα, IL1β, Cxcl2, Ccl2) | - | [55] |
ZnO | 21 | 49.6 | - | Mice (C57BL/6-f) | OVA (Inh) | PA | 2.7 mg/kg | - | ↑ | - | - | - | - | - | nc (HO1, TNFα, IL1β, Cxcl2, Ccl2) | - | [55] |
ZnO (SiO2) | 25 | - | - | Mice (C57BL/6-f) | OVA (Inh) | PA | 2.7 mg/kg | - | ↑ | - | - | - | - | - | - | - | [55] |
SiO2 | 10-20 | 140-180 | - | Rat (Wistar –m) | OVA (IP) | Int T | 1.6 mg/kg x30 | ↑ (Resist) | - | ↓ | - | - | - | - | ↑ (IL-4), nc (INF-γ) | - | [46] |
SiO2 (PEG) | 90 | - | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 22.2 mg/Kg x4 | - | ↑ | ↑ | ↑ | ↑ | nc | ↑ | ↑ (IL-6, IL-5, IL-1β, IL-4, TNF-α, INF-γ | ↑ PAS, MUC5AC | [47] |
SiO2 | 100 | 12.7 | 119.6 | Mice (BALB/c –f) | OVA (Int N) | Int N | 10 mg/kg x6 | ↑ (Resist) | - | ↑ | ↑ | ↑ | nc | ↑ | ↑ (IL-5, IL-13, IL-1β, INF-γ | nc PAS | [48] |
SiO2 (Meso) | 100 | 70.6 | 100.5 | Mice (BALB/c –f) | OVA (Int N) | Int N | 10 mg/kg x6 | ↑ (Resist) | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ (IL-1β, INF-γ) nc (IL-5, IL-13) | ↑ PAS | [48] |
SiO2 (PEG) | 100 | 12.7 | 439.1 | Mice (BALB/c –f) | OVA (Int N) | Int N | 10 mg/kg x6 | nc (Resist) | - | nc | nc | nc | nc | nc | ↑ (INF-γ) nc (IL-1β, IL-5, IL-13) | nc PAS | [48] |
TiO2 | 21 | - | 1.5 μm | Mice (BALB/c –f) | OVA (IP) | A (Nose only) | 193μg, deposited | nc (resist) | ↓ | ↓ | nc | ↓ | nc | ↓ | ↓ (IL-5, IL-6, INF-γ, IL-13, IL-4) | - | [120] |
TiO2 (SiO2) | 10x40 | 132 | 100 | Mice (BALB/c –f) | OVA (IP) | A | 10mg/m3 2h/d x12d | ↓ (Penh) | nc | ↓ | nc | ↓ | ↓ | - | ↓ (IL-1β, TNF-α, IL-4, IL-13, IL-10) | ↓ PAS | [81] |
TiO2 | 4-8 | 130 | 244 | Mice (BALB/c) | OVA (IP) | Int N | 11 mg/kg | ↑ (Resist) | ↑ | - | - | - | - | - | nc (IL-5) ↑ (IL-4, IL-13,IL-6, TNFa) | - | [273] |
ZnO | 50 | 10.8 | - | Mice (Balb/c –f) | OVA (OA) | OA | 0.5 mg/kg x2 | - | nc | ↑ | - | - | - | ↑ | ↑ (IL-4, IL-5, IL-6, IL-13) | - | [56] |
CNF | D-35, L-10μm | 103 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | nc | nc | nc | nc | nc | nc (MCP-1, TNF-α) | - | [54] |
CNF | D- 36, L-5μm | 124 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | nc | ↑ | nc | ↑ | ↑ | nc (MCP-1, TNF-α) | - | [54] |
CNF | D-70, L-5μm | 56 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | nc | nc | nc | nc | nc | nc (MCP-1, TNF-α) | - | [54] |
CNF | D- 83, L-10μm | 61 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | nc | ↑ | nc | nc | ↑ | nc (MCP-1, TNF-α) | - | [54] |
SWCNT | D- 1.1, L-100μm | 543 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | nc (MCP-1, TNF-α) | - | [54] |
MWCNT | D20-30, L-200μm | 140 | - | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | ↑ | ↑ | nc | ↑ | ↑ | nc (MCP-1, TNF-α) | - | [54] |
C (PrinteX 90) | 14 | 300 |  | Mice (BALB/c –f) | OVA (IP) | Int N | 7.4mg/kg x3 | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑(MCP-1), nc (TNF-α) | - | [54] |
SWCNT | D 1.2-2, L 1-15μm | - | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.3 mg/kg x7 | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ (IL4, IL33, IL5, IL13, INFγ, IL17) | ↑ MUC5AC | [52] |
SWCNT | D 0.8-1.2, L 0.1-1μm | - | - | Mice (ICR –m) | OVA (Int T) | Int T | 1.3 mg/kg x7 | - | ↑ | ↑ | ↑ | ↑ | nc | ↑ | ↑ (IL5, IL13) | ↑ MUC5AC | [52] |
MWCNT | D ~15 nm, L 1-10μm | - | - | Mice (BALB/c –m) | OVA (Int N) | Int N | 1mg/kg | ↑ (sRaw) | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ (IL-4, IL-5, IL-13, IL-17) | - | [50] |
SWCNT | D 0.93-1.63 | - | - | Rat (Wistar –m) | OVA (Int T) | Int T | 2 mg/kg x13 | ↑ (Resist) | ↑ | ↑ | ↑ | ↑ | - | ↑ | ↑ (IL4, ROS) ↓(INFγ) | ↑ PAS | [53] |
MWCNT | D ~15 nm, L 1-10μm | - | ~350 μm | Mice (BALB/c –m) | HDM (Int N) | Int N | 12.5mg/kg x10 | - | - | ↑ | ↑ | ↑ | ↑ | ↑ | ↑ IL-13, TGF-β1, IL-33, TSLP, IL-25 | ↑ mucin | [51] |
MWCNT | D 67, L 0.1-10μm | 26 | - | Mice (ICR –m) | OVA (Int I) | Int T | 4.6 mg/kg x6 | - | ↑ | ↑ | ↑ | ↑ | nc | ↑ | ↑ (IL-4, INF-γ, IL-33, IL-1β, TARC, MCP-1) | ↑ PAS | [49] |
MWCNT | D 2–20, L 0.1-10μm | - | - | Mice (ICR –m) | OVA (Int I) | Int T | 4.6 mg/kg x6 | - | ↑ | ↑ | ↑ | ↑ | nc | ↑ | ↑ (IL-4, INF-γ, IL-33, MCP-1, IL-1β); | - | [49] |
SiO2 | 33 | - | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 13.8 mg/kg x3 | - | ↑ | - | - | - | - | - | ↑ (IL-4, IL-5) | - | [45] |
SiO2 | 79 | - | - | Mice (BALB/c –f) | OVA (Int N) | Int N | 13.8 mg/kg x3 | - | nc | - | - | - | - | - | nc (IL-4, IL-5) | - | [45] |